Drug Shortage Report for TEVA-ALENDRONATE

Last updated on 2018-10-11 History
Report ID 43116
Drug Identification Number 02261715
Brand name TEVA-ALENDRONATE
Common or Proper name ALENDRONATE
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) ALENDRONIC ACID
Strength(s) 70MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 4
ATC code M05BA
ATC description DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2018-03-01
Estimated end date 2018-08-10
Actual end date 2018-09-15
Shortage status Resolved
Updated date 2018-10-11
Company comments
Health Canada comments
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v6 2018-10-11 French Compare
v5 2018-10-11 English Compare
v4 2018-05-30 French Compare
v3 2018-05-30 English Compare
v2 2018-03-16 French Compare
v1 2018-03-16 English Compare